INAF logo

PT Indofarma Tbk Stock Price

IDX:INAF Community·Rp390.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

INAF Share Price Performance

Rp0
0.00 (0.00%)
Rp0
0.00 (0.00%)
Price Rp0

INAF Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate and overvalued.

5 Risks
0 Rewards

PT Indofarma Tbk Key Details

Rp269.4b

Revenue

Rp445.4b

Cost of Revenue

-Rp176.1b

Gross Profit

Rp526.5b

Other Expenses

-Rp702.6b

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-226.69
-65.37%
-260.84%
-81.2%
View Full Analysis

About INAF

Founded
1918
Employees
900
CEO
. Yeliandriani
WebsiteView website
indofarma.id

PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company offers laboratory, pharmaceutical, and health glass equipment; orthopedic and prosthetic equipment; medical and dental equipment; and reparation of Irradiation / X-ray, electromedical and electrotherapy equipment. It also trades in laboratory, pharmaceutical, and medical equipment; and engages in herb infusion, health support, private polyclinic, general practitioner, dentist, and internet trading applications activities. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk is a subsidiary of PT Bio Farma.

Recent INAF News & Updates

Recent updates

No updates

PT Indofarma Tbk Competitors